CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 66 filers reported holding CUE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $544 | -34.5% | 439 | 0.0% | 0.00% | – |
| Q1 2024 | $830 | -28.4% | 439 | 0.0% | 0.00% | – |
| Q4 2023 | $1,159 | +14.8% | 439 | 0.0% | 0.00% | – |
| Q3 2023 | $1,010 | -37.0% | 439 | 0.0% | 0.00% | – |
| Q2 2023 | $1,602 | +2.2% | 439 | 0.0% | 0.00% | – |
| Q1 2023 | $1,567 | +25.3% | 439 | 0.0% | 0.00% | – |
| Q4 2022 | $1,251 | +25.1% | 439 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 439 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -80.0% | 439 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -16.7% | 439 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 439 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 439 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | – | 439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 890,000 | $7,503,000 | 0.50% |
| Nantahala Capital Management | 1,378,198 | $11,618,000 | 0.43% |
| 683 Capital Management, LLC | 300,000 | $2,529,000 | 0.28% |
| Rock Creek Group, LP | 42,505 | $358,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $422,000 | 0.06% |
| Parian Global Management LP | 11,000 | $93,000 | 0.04% |
| Sigma Planning Corp | 60,210 | $508,000 | 0.02% |
| D'Orazio & Associates, Inc. | 2,000 | $17,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 26,602 | $224,000 | 0.01% |
| STIFEL FINANCIAL CORP | 55,855 | $471,000 | 0.00% |